Suchergebnisse - "Chebli, Julio Maria Fonseca"

PubPharm (92)

1

Interaction between diet and genetics in patients with inflammatory bowel disease

enthalten in: World journal of gastroenterology | 2024

von Magro, D. | Sassaki, L. | Chebli, J.

2

The Role of Pharmacogenetics in the Therapeutic Response to Thiopurines in the Treatment of Inflammatory Bowel Disease : A Systematic Review

enthalten in: Journal of clinical medicine | 2023

von Ribeiro, A. | Gerheim, P. | Chebli, J. | +2

3

Vedolizumab in Mild-to-Moderate Crohn's Disease Patients Naïve to Biological Therapy : A Multicentric Observational Study

enthalten in: Crohn's & colitis 360 | 2023

von Dotti, A. | Magro, D. | Vilela, E. | +19

4

Efficacy of Early Optimization of Infliximab Guided by Therapeutic Drug Monitoring during Induction-A Prospective Trial

enthalten in: Biomedicines | 2023

von Garcia, K. | de Azevedo, M. | Carlos, A. | +14

5

Leukocytoclastic Vasculitis Secondary to Anti-Tumor Necrosis Factor Therapy in Inflammatory Bowel Diseases : A Multicenter Retrospective Cohort Study

enthalten in: Journal of clinical medicine | 2023

von Parra, R. | Chebli, J. | Chebli, L. | +7

6

SECOND BRAZILIAN CONSENSUS ON THE MANAGEMENT OF ULCERATIVE COLITIS IN ADULTS : A CONSENSUS OF THE BRAZILIAN ORGANIZATION FOR CROHN'S DISEASE AND COLITIS (GEDIIB)

enthalten in: Arquivos de gastroenterologia | 2023

von Baima, J. | Imbrizi, M. | Andrade, A. | +31

7

SECOND BRAZILIAN CONSENSUS ON THE MANAGEMENT OF CROHN'S DISEASE IN ADULTS : A CONSENSUS OF THE BRAZILIAN ORGANIZATION FOR CROHN'S DISEASE AND COLITIS (GEDIIB)

enthalten in: Arquivos de gastroenterologia | 2023

von Imbrizi, M. | Baima, J. | Azevedo, M. | +30

8

Effectiveness and Safety of Ustekinumab for Moderate to Severely Active Crohn's Disease : Results from an Early Access Program in Brazil

enthalten in: Journal of clinical medicine | 2022

von Chebli, J. | Parra, R. | Flores, C. | +6

9

Simultaneous Monitoring of Azathioprine Metabolites in Erythrocytes of Crohn's Disease Patients by HPLC-UV

enthalten in: Journal of chromatographic science | 2022

von Ribeiro, A. | Barroso, L. | Mourao-Junior, C. | +2

10

Ustekinumab versus adalimumab for induction and maintenance therapy in biologic-naive patients with moderately to severely active Crohn's disease : a multicentre, randomised, double-blind, parallel-group, phase 3b trial

enthalten in: Lancet (London, England) | 2022

von Sands, B. | Irving, P. | Hoops, T. | +117

CommentIn: Lancet. 2022 Jun 11;399(10342):2169-2171. - PMID 35691307

1
2
3
4
5
6
7
8
9
10
Nächster »
[10]